Our Latest News & Blogs

What You Missed Last Month – November Edition

Lots went on in the 3D Printing field last month. From 3D printed light receptors for prosthetic vision devices to $10 3D ultrasound chips and 3D printing for spinal cord injuries to 3D printed model body parts, a lot went on in the month of November. Here is a quick overview of what you missed:


FDA Approves First Continuous Glucose Monitoring System Not Requiring Blood Sample Calibration

The FDA approved last July the first continuous glucose monitoring system that could free millions of people with diabetes from daily finger sticks.


FDA's ASCA Pilot Program

Agency publishes details for conformity assessment

The US Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) has published additional information on its pilot program for medical device conformity assessment accreditation, known as the Accreditation Scheme for Conformity Assessment, or ASCA.

BioLIFE4D Has Successfully 3D Printed Human Cardiac Tissue

BIOLIFE4D announced earlier this year that it has successfully 3D printed human cardiac tissue demonstrating the ability to 3D bio-print viable tissue for transplant.

The successfully printed cardiac patch contains multiple cell types and included preliminary vascularization. The patches can be used in patients with acute heart failure to restore myocardial contraction.

Heart Implant, 3D Printed to Order

For patients with heart rhythm disorders, current pacemakers and implantable cardioverter defibrillators are “one-size-fits- all” devices that provide narrowly limited information for cardiologists treating patients with the devices.Using 3D printing, researchers at Washington University are developing more precise heart sensors that might lead to tailored treatment for heart conditions like atrial fibrillation.

Get the latest news and blogs about the Medical Device Industry.

Click 'Subscribe' to keep up with the latest trends.

Kapstone Medical is a single-source service provider to medical device companies lacking the appropriate human capital to bring to market new and safe products. We provide customized solutions that are flexible and cost effective in an ever changing regulatory environment.


BBB accredited

Get to Market

Contact Info

Our Tweets